Cargando…
Production of Recombinant Gelonin Using an Automated Liquid Chromatography System
Advances in recombinant DNA technology have opened up new possibilities of exploiting toxic proteins for therapeutic purposes. Bringing forth these protein toxins from the bench to the bedside strongly depends on the availability of production methods that are reproducible, scalable and comply with...
Autores principales: | Berstad, Maria E. B., Cheung, Lawrence H., Weyergang, Anette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472732/ https://www.ncbi.nlm.nih.gov/pubmed/32823678 http://dx.doi.org/10.3390/toxins12080519 |
Ejemplares similares
-
Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization
por: Olsen, Cathrine Elisabeth, et al.
Publicado: (2019) -
Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin
por: Dietze, A, et al.
Publicado: (2005) -
Molecularly engineered tumor acidity-responsive plant toxin gelonin for safe and efficient cancer therapy
por: Ding, Guo-Bin, et al.
Publicado: (2022) -
Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
por: Yuan, Xiaoqin, et al.
Publicado: (2011) -
Fusion Toxin BLyS-Gelonin Inhibits Growth of Malignant Human B Cell Lines In Vitro and In Vivo
por: Luster, Troy A., et al.
Publicado: (2012)